Olufunmilayo Olopade to Insulin-Like Growth Factor II
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Insulin-Like Growth Factor II.
Connection Strength
0.130
-
Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer Epidemiol Biomarkers Prev. 2011 Aug; 20(8):1690-702.
Score: 0.102
-
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):145-53.
Score: 0.029